Circulating CD62E+ microparticles and cardiovascular outcomes

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lee, Soon Tae ^a,b   Chu, Kon ^a,b   Jung, Keun Hwa ^a,b   Kim, Jeong Min ^a   Moon, Hye Jin ^a   Bahn, Jae Jun ^a   Im, Woo Seok ^a   Sunwoo, Junsang ^a   Moon, Jangsup ^a   Kim, Manho ^a,b   Lee, Sang Kun ^a,b   Roh, Jae Kyu ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; BIOLOGICAL MARKER; LIPOCORTIN 5; THROMBIN RECEPTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL MICROPARTICLE; EVENT FREE SURVIVAL; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PROTEIN EXPRESSION; RISK FACTOR; STROKE; BLOOD; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FOLLOW UP; MEMBRANE MICROPARTICLE; METABOLISM; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ANNEXIN A5; ANTIGENS, CD31; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; DISEASE-FREE SURVIVAL; E-SELECTIN; ENDOTHELIAL CELLS; FOLLOW-UP STUDIES; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE;

EID: 84860372848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035713     Document Type: Article

References (33)

1. Zeiher AM, Drexler H, Wollschlager H, Just H, (1991) Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-1992.
2. De Caterina R, Massaro M, Scoditti E, Annunziata Carluccio M, (2010) Pharmacological modulation of vascular inflammation in atherothrombosis. Ann N Y Acad Sci 1207: 23-31.
3. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, et al. (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145: 962-970.
4. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, et al. (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180.
5. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R, (2005) Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288: H1004-1009.
6. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, et al. (2004) Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 110: 3599-3603.
7. Horstman LL, Jy W, Jimenez JJ, Ahn YS, (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9: 1118-1135.
8. Jung KH, Chu K, Lee ST, Park HK, Bahn JJ, et al. (2009) Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol 66: 191-199.
9. Rossig L, Haendeler J, Mallat Z, Hugel B, Freyssinet JM, et al. (2000) Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol 36: 2081-2089.
10. van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, et al. (2006) P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 52: 657-664.
11. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, et al. (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51: 2840-2845.
12. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, et al. (2006) Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26: 2530-2535.
13. Brogan PA, Shah V, Brachet C, Harnden A, Mant D, et al. (2004) Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 50: 927-936.
14. Amabile N, Rautou PE, Tedgui A, Boulanger CM, (2010) Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 36: 907-916.
15. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, et al. (2009) Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 28: 1081-1086.
16. Yun CH, Jung KH, Chu K, Kim SH, Ji KH, et al. (2010) Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol 6: 89-98.
17. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
19. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, et al. (2004) Measuring circulating cell-derived microparticles. J Thromb Haemost 2: 1842-1851.
20. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M, (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467.
21. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015-2022.
22. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
23. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
24. Rand ML, Wang H, Bang KW, Packham MA, Freedman J, (2006) Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 4: 1621-1623.
25. Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, et al. (2011) Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32: 2034-2041.
26. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G, (2006) Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26: 112-116.
27. Arteaga RB, Chirinos JA, Soriano AO, Jy W, Horstman L, et al. (2006) Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98: 70-74.
28. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, et al. (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16: 3381-3388.
29. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, et al. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652.
30. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS, (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286: H1910-1915.
31. Kushak RI, Nestoridi E, Lambert J, Selig MK, Ingelfinger JR, et al. (2005) Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res 116: 409-419.
32. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, et al. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104: 93-102.
33. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, et al. (2002) Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99: 3962-3970.